AYUSH – GCP Dr Sathiya Rajeswaran Research Officer SCRI,CCRS,Chennai All roads meet a common goal Roads are different goal is same • ICMR • WHO. ‘Good Clinical Practice Guidelines’ published by AYUSH Ministry for clinical trials of Ayurveda, Siddha & Unani drugs. There are four Research. The department of Ayush has issued good clinical practice (GCP) guidelines for clinical trials in Ayurveda, Siddha and Unani (ASU) medicines.
|Published (Last):||4 February 2008|
|PDF File Size:||2.25 Mb|
|ePub File Size:||5.49 Mb|
|Price:||Free* [*Free Regsitration Required]|
In clinical trials, an untoward medical occurrence seemingly caused by overdosing, abuse dependence and interactions with other medicinal products is also considered as an ADR. If we attempt to do so, the global scientific community should also benefit, where the relevance of RCTs in the light of integrative medicine has already been greatly guidelinfs for better alternatives. Remember me on this computer. In the case of chronic diseases, the effect size for systematic remission or cure using the present drug treatments is very low.
Good Clinical Practice Guidelines for clinical trials of ASU Medicine
To summarize, when the world is waking up and seriously debating the need for newer models for clinical research, Indian guidelines for ASU should not get overwhelmed by the RCT approach of biomedicine.
In fact, we need to evolve appropriate guidelines based on the basic principles of Ayurveda where due weightage is given to empirical evidence. The audit should also compare data on the Source Documents with the interim or final report.
A catalogue of reporting guidelines for health research. J Asso Physicians India. The objective of this page log document is to encourage that clinical studies in ASU systems are undertaken in accordance with ethical and scientific standards and safety aspects and rights of participants are protected. Therefore, Indian scientists and regulators should design GCP guidelines after considering the gudielines differences between Ayurveda and Western biomedicine.
Well controlled, double-blind, placebo-controlled trials of classical Ayurvedic treatment are possible in rheumatoid arthritis. In case of many chronic diseases, life expectancy and quality of life are reduced with a risk guidelinfs iatrogenic disease. Miller FG, Joffe S. Such trials may also evaluate whole system interventions implemented under defined manuals and protocols, to specify individualized treatments based on specific patient characteristics.
The GCP guidelines are likely to assist the researchers and institutions in following a customary way of good clinical practice while carrying out human trials for ISM medicines. Support Center Support Center.
The guidelines fulfill a long felt need to guide the direction of clinical trials on ASU remedies and therapies. Such studies are generally guifelines in later Phases but may be appropriate when drug activity is readily measurable with a short duration of drug exposure in patients at this early stage.
These studies include both single and multiple dose administration. However, all paediatric participants should be informed to the fullest extent possible about the study in a language and in terms that they are able to understand.
Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach
The question of whether treatment is drug-based, or herbal, or other is irrelevant. Enter the email address you signed up with and we’ll email you a reset link.
Scientific unbiasedness is different from unbiasedness that is used generally. Efficacy and safety of Ayurvedic medicines: EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda.
The case of Ayurveda, however, is different as the treatment regimen guideline already in use.
National Institute of Siddha, Chennai, IN – GCP – AYUSH Guidelines
A proposed new discipline. J Alt Compl Med. J Altern Complement Med. The arguments of having long standing in the medical practice or market are often unconvincing and there has been persistent guicelines increasing demand of documented proof of clinical giudelines and efficacy of ASU medicine. In case of Ayurveda for instance, patients are already using its treatments and therefore effectiveness studies can guide the necessity of studying the efficacy of specific components.
The guidelines are addressed to investigators and all those, who are interested, concerned, involved and affected with the conduct of clinical trials on ASU drugs. These guidelines are intended to serve as a reference source for research scientists, registered medical practitioners, manufacturers, and health authorities. However, blinding of the guidflines to the evaluators can ensure an unbiased comparison.